» Authors » Swee Ho Lim

Swee Ho Lim

Explore the profile of Swee Ho Lim including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 33
Citations 276
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamzah J, Phua J, Chan W, Teo S, Tan V, Lim G, et al.
Clin Imaging . 2024 Oct; 116:110308. PMID: 39423691
Aim: Mammography is the mainstay of imaging surveillance after breast cancer (BC) treatment, but false negatives can occur. The objective of the study was to determine the factors that can...
2.
Ong S, Ho P, Khng A, Tan B, Tan Q, Tan E, et al.
Int J Mol Sci . 2024 Aug; 25(16). PMID: 39201744
Idiopathic granulomatous mastitis (IGM) is a rare condition characterised by chronic inflammation and granuloma formation in the breast. The aetiology of IGM is unclear. By focusing on the protein-coding regions...
3.
Lim G, Wong R, Alcantara V, Ng R, Tan Q, Lim S, et al.
Gland Surg . 2023 Jun; 12(5):586-592. PMID: 37284720
Background: One of the manifestations of recurrence after mastectomy is the presentation of chest wall lesion. However, it is unclear if the size of the chest wall recurrence (CWR) is...
4.
Lim G, Alcantara V, Ng R, Htein M, Tan Q, Lim S, et al.
Ann Transl Med . 2023 Apr; 11(6):240. PMID: 37082687
Background: National Comprehensive Cancer Network (NCCN) guidelines on the axillary management of breast cancer patients with isolated chest wall recurrence after mastectomy are unclear. Though sentinel lymph node biopsy (SLNB)...
5.
Ong S, Xu J, Sim C, Khng A, Ho P, Kwan P, et al.
Int J Mol Sci . 2023 Jan; 24(2). PMID: 36674562
Idiopathic granulomatous mastitis (IGM) is a rare and benign inflammatory breast disease with ambiguous aetiology. Contrastingly, lactational mastitis (LM) is commonly diagnosed in breastfeeding women. To investigate IGM aetiology, we...
6.
Lim G, Alcantara V, Ng R, Ng R, Allen J, Htein M, et al.
Breast Cancer Res Treat . 2022 Oct; 196(3):583-589. PMID: 36287308
Introduction: Little is known about second recurrences in breast cancer patients, especially in patients with mastectomy. We aimed to determine the risk factors, prevalence and patterns of second recurrence in...
7.
Ong S, Ho P, Khng A, Lim E, Wong F, Tan B, et al.
Cancers (Basel) . 2022 Jun; 14(11). PMID: 35681694
Background: The hypothesis that breast cancer (BC) susceptibility variants are linked to chemotherapy-induced toxicity has been previously explored. Here, we investigated the association between a validated 313-marker-based BC polygenic risk...
8.
Ang B, Ho W, Wijaya E, Kwan P, Ng P, Yoon S, et al.
J Clin Oncol . 2022 Feb; 40(14):1542-1551. PMID: 35143328
Purpose: With the development of poly (ADP-ribose) polymerase inhibitors for treatment of patients with cancer with an altered or gene, there is an urgent need to ensure that there are...
9.
Lim J, Koh J, Ho P, Liu J, Lim S, Tan E, et al.
Value Health Reg Issues . 2022 Feb; 29:108-115. PMID: 35104748
Objectives: Advances in adjuvant therapy have led to increased survival rates after cancer prognosis. Herceptin, a targeted therapy, had first been introduced to Singapore in 2006. We aimed to assess...
10.
Mavaddat N, Dorling L, Carvalho S, Allen J, Gonzalez-Neira A, Keeman R, et al.
JAMA Oncol . 2022 Jan; 8(3):e216744. PMID: 35084436
Importance: Rare germline genetic variants in several genes are associated with increased breast cancer (BC) risk, but their precise contributions to different disease subtypes are unclear. This information is relevant...